Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1969;40:IV-155-IV-163

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GORLIN, R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by GORLIN, R.

(Circulation. 1969;40:IV-155.)
© 1969 American Heart Association, Inc.


Evaluation of Myocardial Metabolism in Ischemic Heart Disease

RICHARD GORLIN M.D.1

1 Dr. Gorlin is Chief of the Cardiovascular Division, Peter Bent Brigham Hospital; Associate Professor of Medicine, Harvard Medical School, Boston, Massachusetts; and Investigator, Howard Hughes Medical Institute.

Metabolism of the human heart during myocardial infarction may be studied by means of arterial and coronary sinus catheterization at little risk, but definite inconvenience. Ischemia has been readily detected through myocardial production or release of lactate, potassium, hydrogen, and certain enzymes. These findings may be of help in identifying the presence of acute myocardial injury or infarction and in evaluation of applied therapy. Other studies, particularly of metabolized substrates, including oxygen, have been less rewarding. The patchy nature of coronary atherosclerosis and its partial compensation by collateral vessels renders coronary venous inflow nonuniform. This makes interpretation of the meaning of the concentration of substances contained within the coronary venous effluent extremely difficult. Multiple-site venous sampling is particularly helpful in overcoming this inherent defect in the method.